Piedmont Realty Trust, Inc. Stock Compensation Disclosure
| Shares | Weighted-Average Grant Date Fair Value | ||||||||||
Unvested and Potential Stock Awards as of December 31, 2024 | 3,018,435 | $ | 9.20 | ||||||||
Deferred Stock Awards Granted | 560,810 | $ | 8.15 | ||||||||
| Performance Stock Awards Granted | 509,686 | $ | 10.05 | ||||||||
Change in Estimated Potential Share Awards based on TSR Performance | 597,635 | $ | 10.71 | ||||||||
Performance Stock Awards Vested | (269,079) | $ | 13.56 | ||||||||
Deferred Stock Awards Vested | (454,161) | $ | 9.04 | ||||||||
Deferred Stock Awards Forfeited | (9,472) | $ | 8.23 | ||||||||
Unvested and Potential Stock Awards as of December 31, 2025 | 3,953,854 | $ | 9.13 | ||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
Weighted-Average Grant Date Fair Value per share of Deferred Stock Granted During the Period | $ | 8.15 | $ | 7.89 | $ | 9.60 | |||||||||||
Total Grant Date Fair Value of Deferred Stock Vested During the Period | $ | 4,104 | $ | 6,235 | $ | 5,448 | |||||||||||
| Date of grant | Type of Award | Net Shares Granted (1) | Grant Date Fair Value | Vesting Schedule | Unvested and Potential Shares as of December 31, 2025 | ||||||||||||||||||||||||||||||
| February 13, 2023 | Deferred Stock Award | 293,316 | $ | 10.55 | Of the shares granted, 25% vested on the date of grant, and 25% will vest on February 13, 2024, 2025, 2026, respectively. | 83,852 | |||||||||||||||||||||||||||||
| February 23, 2023 | Fiscal Year 2023-2025 Performance Share Program | — | $ | 12.37 | Shares awarded, if any, will vest immediately upon determination of award in 2026. | 471,324 | (2) | ||||||||||||||||||||||||||||
| February 23, 2023 | Deferred Stock Award | 315,943 | $ | 9.47 | Of the shares granted, 25% will vest on February 23, 2024, 2025, 2026, and 2027 respectively. | 161,468 | |||||||||||||||||||||||||||||
| February 20, 2024 | Fiscal Year 2024-2026 Performance Share Program | — | $ | 7.64 | Shares awarded, if any, will vest immediately upon determination of award in 2027. | 1,035,878 | (2) | ||||||||||||||||||||||||||||
| February 20, 2024 | Deferred Stock Award | 466,249 | $ | 6.55 | Of the shares granted, 25% will vest on February 23, 2024, 2025, 2026, and 2027 respectively. | 351,387 | |||||||||||||||||||||||||||||
| October 1, 2024 | Deferred Stock Award | 60,606 | $ | 9.90 | Of the shares granted, 25% will vest on October 1, 2025, 2026, 2027, and 2028 respectively. | 45,455 | |||||||||||||||||||||||||||||
| October 28, 2024 | Deferred Stock Award | 322,101 | $ | 10.09 | Of the shares granted, 100% will vest on October 28, 2029. | 322,101 | |||||||||||||||||||||||||||||
| February 3, 2025 | Deferred Stock Award | 429,334 | $ | 8.52 | Of the shares granted, 25% will vest on February 3, 2026, 2027, 2028, and 2029 respectively. | 423,100 | |||||||||||||||||||||||||||||
| February 3, 2025 | 2025-2027 Performance Share Program | — | $ | 10.05 | Shares awarded, if any, will vest immediately upon determination of award in 2028. | 937,553 | |||||||||||||||||||||||||||||
| May 15, 2025 | Deferred Stock Award-Board of Directors | 121,736 | $ | 6.90 | Of the shares granted, 100% will vest on the earlier of the 2026 Annual Meeting or May 15, 2026. | 121,736 | |||||||||||||||||||||||||||||
| Total | 3,953,854 | ||||||||||||||||||||||||||||||||||
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.